A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples